Affiliation:
1. From the Neurovascular Unit for Applied Translational Research and Therapeutics, Mater University Hospital/Dublin Academic Medical Centre, University College Dublin, Ireland (D.N.C., E.C., N.H., P.J.K.); Department of Medicine, University Hospital, Umeå, Sweden (K.A., F.J.); Department of Medical Sciences, Uppsala University, Sweden (S.A.); Neurology Department, Hospital del Mar-IMIM. Barcelona (E.C.-G.); Department of Neurology and Stroke Center, La Paz University Hospital, Autónoma de Madrid...
Abstract
Background and Purpose—
Although experimental data suggest that statin therapy may improve neurological outcome after acute cerebral ischemia, the results from clinical studies are conflicting. We performed a systematic review and meta-analysis investigating the relationship between statin therapy and outcome after ischemic stroke.
Methods—
The primary analysis investigated statin therapy at stroke onset (prestroke statin use) and good functional outcome (modified Rankin score 0 to 2) and death. Secondary analyses included the following: (1) acute poststroke statin therapy (≤72 hours after stroke), and (2) thrombolysis-treated patients.
Results—
The primary analysis included 113 148 subjects (27 studies). Among observational studies, statin treatment at stroke onset was associated with good functional outcome at 90 days (pooled odds ratio [OR], 1.41; 95% confidence interval [CI], 1.29–1.56;
P
<0.001), but not 1 year (OR, 1.12; 95% CI, 0.9–1.4;
P
=0.31), and with reduced fatality at 90 days (pooled OR, 0.71; 95% CI, 0.62–0.82;
P
<0.001) and 1 year (OR, 0.80; 95% CI, 0.67–0.95;
P
=0.01). In the single randomized controlled trial reporting 90-day functional outcome, statin treatment was associated with good outcome (OR, 1.5; 95% CI, 1.0–2.24;
P
=0.05). No reduction in fatality was observed on meta-analysis of data from 3 randomized controlled trials (
P
=0.9). In studies restricted to of thrombolysis-treated patients, an association between statins and increased fatality at 90 days was observed (pooled OR, 1.25; 95% CI, 1.02–1.52;
P
=0.03, 3 studies, 4339 patients). However, this association was no longer present after adjusting for age and stroke severity in the largest study (adjusted OR, 1.14; 95% CI, 0.90–1.44; 4012 patients).
Conclusion—
In the largest meta-analysis to date, statin therapy at stroke onset was associated with improved outcome, a finding not observed in studies restricted to thrombolysis-treated patients. Randomized trials of statin therapy in acute ischemic stroke are needed.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)
Cited by
208 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献